Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US
population. This guideline addresses important clinical questions that arise in psoriasis …

… Gottlieb MD, PhD f , Paolo Gisondi MD g , Jashin J. Wu MD h , Jacob P. Thyssen MD, PhD,
DMSc a , Alexander Egeberg MD, PhD a … https://doi.org/10.1016/j.jaad.2018.06.027…

… Wu et al performed a retrospective cohort study on 8845 psoriasis patients using data obtained
from a health maintenance organization database (Table IV). The study included 1637 patients …

Background Early clinical studies suggested that the anti–interleukin-17 receptor A monoclonal
antibody brodalumab has efficacy in the treatment of psoriasis. Methods In two phase 3 …

… To my parents Shin Wu, MD and Jane Joaquin-Wu, MD, who installed in me the value of
hard … I am very grateful for the expert assistance from my Associate Editor Jashin J. Wu, MD. …

Objective To assess whether patients with psoriasis treated with tumor necrosis factor (TNF)
inhibitors have a decreased risk of myocardial infarction (MI) compared with those not …

Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the
United States population. This guideline addresses important clinical questions that arise in …

BACKGROUND: Previous studies provide evidence that there is a greater frequency of
autoimmune diseases among patients with psoriasis than in the general population. OBJECTIVE: …

Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting
approximately 2% of the world's population. In this guideline, we focus the discussion on …

Background An urgent need exists in the United States to establish treatment goals in
psoriasis. Objective We aim to establish defined treatment targets toward which clinicians and …